DETECTION OF CORONARY VASOSPASM BY POSTHYPERVENTILATION TC-99M SESTAMIBI SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY IMAGINE IN PATIENTS WITH CORONARY-ARTERY DISEASE

Citation
H. Shanoudy et al., DETECTION OF CORONARY VASOSPASM BY POSTHYPERVENTILATION TC-99M SESTAMIBI SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY IMAGINE IN PATIENTS WITH CORONARY-ARTERY DISEASE, The American journal of cardiology, 81(5), 1998, pp. 573-577
Citations number
23
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
00029149
Volume
81
Issue
5
Year of publication
1998
Pages
573 - 577
Database
ISI
SICI code
0002-9149(1998)81:5<573:DOCVBP>2.0.ZU;2-L
Abstract
Forced hyperventilation is simple, safe to perform, and can be used as a provocative test for coronary vasospasm. This study assesses whethe r a vasospastic component of angina might be detected in patients with angiographically ''nonobstructive'' coronary artery disease by posthy perventilation technetium-99m (Tc-99m) sestamibi single-photon emissio n computed tomography (SPECT) cardiac imaging, Eleven patients with an giographically nonobstructive coronary artery disease underwent Tc-99m sestamibi SPECT imaging at rest and after forced hyperventilation. Ve ssel diameters were measured by quantitative angiography before and af ter forced hyperventilation, and posthyperventilation SPECT images wer e compared with dipyridamole Tc-99m sestamibi stress images, Forced hy perventilation resulted in a 15% reduction in coronary artery diameter in stenotic segments (p < 0.01), and a 17% reduction in adjacent nons tenotic segments (p < 0.001). Myocardial uptake of Tc-99m sestamibi in segments perfused by vessels with angiographically nonobstructive ste noses was reduced 24% following forced hyperventilation (p < 0.001) co mpared with only 4% following dipyridamole (p < 0.02), These findings suggest that posthyperventilation Tc-99m sestamibi SPECT imaging in pa tients with angina pectoris and nonobstructive coronary artery disease may be useful in identifying a vasospastic component of angina. (C) 1 998 by Excerpta Medico, Inc.